Search Results - "Efferson, Clay L"

  • Showing 1 - 18 results of 18
Refine Results
  1. 1
  2. 2

    Clinical Studies of Vaccines Targeting Breast Cancer by KO, Byung K, KAWANO, Kouichiro, MURRAY, James L, DISIS, Mary L, EFFERSON, Clay L, KUERER, Henry M, PEOPLES, George E, IOANNIDES, Constantin G

    Published in Clinical cancer research (15-08-2003)
    “…Many clinical studies have been undertaken to assess the therapeutic potential of vaccination and have included a large variety of cancer immunogens. Most of…”
    Get full text
    Journal Article
  3. 3
  4. 4
  5. 5

    Inhibition of Tumor Growth Progression by Antiandrogens and mTOR Inhibitor in a Pten-Deficient Mouse Model of Prostate Cancer by WEISHENG ZHANG, ZHU, Joe, SUR, Cyrille, MAJUMDER, Pradip K, EFFERSON, Clay L, WARE, Chris, TAMMAM, Jennifer, ANGAGAW, Minilik, LASKEY, Jason, BETTANO, Kimberly A, KASIBHATLA, Shailaja, REILLY, John F

    Published in Cancer research (Chicago, Ill.) (15-09-2009)
    “…Androgen receptors have been shown to play a critical role in prostate cancer. We used ultrasound imaging techniques to track tumor response to antiandrogen…”
    Get full text
    Journal Article
  6. 6

    A peptidoglycan monomer with the glutamine to serine change and basic peptides bind in silico to TLR-2 (403–455) by Li, Yufeng, Efferson, Clay L., Ramesh, Rajagopal, Peoples, George E., Hwu, Patrick, Ioannides, Constantin G.

    Published in Cancer Immunology, Immunotherapy (01-04-2011)
    “…Bacterial cell wall polysaccharides, such as PGN, bind and activate TLR-2, NOD2 and PGRP on monocytes/macrophages and activate inflammation. We found that the…”
    Get full text
    Journal Article
  7. 7

    Synthetic microRNA and double-stranded RNA targeting the 3'-untranslated region of HER-2/neu mRNA inhibit HER-2 protein expression in ovarian cancer cells by Tsuda, Naotake, Kawano, Kouichiro, Efferson, Clay L, Ioannides, Constantin G

    Published in International journal of oncology (01-11-2005)
    “…MicroRNA (miRNA) are a class of non-coding RNAs found both in normal tissues and cancer cells. The natural miRNA, which target cancer genes for transcriptional…”
    Get more information
    Journal Article
  8. 8
  9. 9

    Sensitivity of undifferentiated, high-TCR density CD8+ cells to methylene groups appended to tumor antigen determines their differentiation or death by KAWANO, Kouichiro, EFFERSON, Clay L, PEOPLES, George E, CARTER, Darrick, TSUDA, Naotake, MURRAY, James L, IOANNIDES, Constantin G

    Published in Cancer research (Chicago, Ill.) (01-04-2005)
    “…CD8(+) cells expressing high numbers of TCR per cell (TCR(hi)) are considered important mediators of antitumor effects. To understand the relationship between…”
    Get full text
    Journal Article
  10. 10

    Mitogen stimulation activates different signaling pathways in early- and late-divided T cells as revealed by cDNA microarray analysis by Li, Yufeng, Wong, Kwong-Kwok, Matsueda, Satoko, Efferson, Clay L, Chang, David Z, Ioannides, Constantin G, Tsuda, Naotake

    “…Mobilization of tumor-reactive CD8+ T cells remains the major challenge of cancer immunotherapy. Knowing how and when the T cell response expands and…”
    Get full text
    Journal Article
  11. 11
  12. 12
  13. 13
  14. 14

    Helper peptide G89 (HER-2:777-789) and G89-activated cells regulate the survival of effectors induced by the CTL epitope E75 (HER-2, 369-377). Correlation with the IFN-gamma: IL-10 balance by Lee, Tom V, Johnston, Dennis A, Thomakos, Nicholas, Honda, Toshie, Efferson, Clay L, Ioannides, Constantin G

    Published in Anticancer research (01-05-2002)
    “…The CTL response to Ag expands after priming and subsequently contracts reducing the number of effectors. CD4+ cells are described as regulators of CTL…”
    Get more information
    Journal Article
  15. 15

    Treatment with HER-2 phosphorylation agonists enhance tumor ability to stimulate epitope specific CTL in vitro by Castilleja, Agapito, Ward, Nancy E, Epstein, Richard B, Kudelka, Andrzej P, Gershenson, David M, Efferson, Clay L, O'Brian, Catherine A, Ioannides, Constantin G

    Published in Oncology reports (01-09-2002)
    “…The transmembrane (TM) receptor encoded by the HER-2 proto-oncogene (HER-2) is amplified in several types of human carcinomas and premalignant states and…”
    Get more information
    Journal Article
  16. 16

    Inhibition of Notch by gamma‐secretase inhibitors induces apoptosis through activated caspase‐3 in LS‐1034 colon cancer model by Efferson, Clay L, Elbi, Cem, Tammam, Jennifer, Carroll, Pamela, Kohl, Nancy E, Majumder, Pradip K

    Published in The FASEB journal (2007)
    “…The Notch pathway is an evolutionarily conserved regulator of cellular differentiation in many tissues during development and later through adult life. It has…”
    Get full text
    Journal Article
  17. 17

    Sensitivity of Undifferentiated, High-TCR Density CD8 super(+) Cells to Methylene Groups Appended to Tumor Antigen Determines Their Differentiation or Death by Kawano, Kouichiro, Efferson, Clay L, Peoples, George E, Carter, Darrick, Tsuda, Naotake, Murray, James L, Ioannides, Constantin G

    Published in Cancer research (Chicago, Ill.) (01-04-2005)
    “…CD8 super(+) cells expressing high numbers of TCR per cell (TCR super(hi)) are considered important mediators of antitumor effects. To understand the…”
    Get full text
    Journal Article
  18. 18